Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

Clinical trial NCT07447570 · RECRUITING

Trial details

NCT number: NCT07447570
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Radiotherapy Anti-PD-1/CTLA-4 Antibody

Start date: 2025-10-15
Primary completion: 2027-12-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.